Introduction
============

Mitochondrial diseases are a heterogeneous group of disorders caused by mutations in the mitochondrial DNA (mtDNA), but also in nuclear genes \[[@b1]--[@b3]\]. These nuclear-derived factors important for replication and transcription of the mtDNA include the human mitochondrial transcription factor A (h-mtTFA), DNA poly-merase, (Pol γ) and mitochondrial single stranded binding protein (mtSSB) \[[@b4], [@b5]\]. The disorders involve mostly skeletal muscle and brain, but other organs may also be affected. In this context, liver failure due to depletion of mtDNA is relatively common \[[@b6]--[@b11]\].

Depletion of mtDNA may be caused by mutations in different genes. Mutations in the gene encoding the catalytic subunit of polymerase γ\[[@b12]--[@b14]\] are associated with depletion of mtDNA and subsequently liver failure and have been described most often in Alpers-Huttenlocher disease \[[@b15]--[@b19]\]. However, these mutations were also found in a wide spectrum of other clinical disorders, including autosomally inherited progressive external ophthalmoplegia, sensory-neural neuropathy, ataxia, epilepsy and parkinsonism \[[@b20], [@b21]\]. Therefore, an interesting question is how other coexisting metabolic alterations might influence the clinical presentation \[[@b22]\].

In this study, we describe the morphological, cyto-immunocy-tochemical, biochemical and molecular genetic results in a 16-months old child, who died of liver failure due to mutations in the polymerase γ (POLG) gene. Our study showed heterogenic tissue involvement with a mosaic defect pattern in the liver probably related to concomitant secondary dysfunction of further proteins involved in mtDNA maintenance like mitochondrial single stranded binding protein (mtSSB) and mitochondrial transcription factor A (mtTFA). The results help to explain the occasionally observed recovery from mtDNA depletion and indicate also that a slight increase in the mtDNA copy number might be enough to retain the normal respiratory function, which may open possibilities for therapeutic trials in the future.

Materials and methods
=====================

Case report
-----------

The patient, a boy, was the first child of healthy non-consanguineous/ genetically unrelated parents. There was no history of miscarriage in the family and the history of the family was negative for liver disease.

Pregnancy and delivery were normal (birth weight 3920 g, APGAR 6/9/10). Psychomotor development was normal during the first 4 months of life, he started smiling at 2 months and to grasp objects at 4 months of age. At the age of 5 months the patient developed recurrent vomiting and failure to thrive. Liver enzymes at the age of 6 months were: 200 U/L for AST, 107 U/L for ALT and 507 U/L for -γ-glutamyl-transferase, but total bilirubin was normal. In parallel with deterioration of liver function psychomotor retardation was noticed and the ability to grasp objects and to roll over was lost. The muscle tone was increased. EEG, as well as MRI and MR-spectroscopy of the brain at the age of 7--8 months were inconspicuous. Epileptic episodes have not been observed. Serum lactate was slightly elevated (2.8--3.7 mmol/l). Extensive clinical search did not reveal the etiology of the liver disease. There was a normal level of alpha-1-antitrypsine coeruloplasmin, copper. Serological test for hepatitis A/B/C, CMV, EVB, rubella, toxoplasmosis and HSV1 were negative. Immunological screening did not detect ANAs, ANCAs, ds-ANAs, Gliadin-antibodies. Cystic fibrosis was excluded by iontophoresis. There were no clinical signs of a cardiomy-opathy and sonography of the heart proved unconspicuous. In the following months, gastrointestinal problems recurred because of persisting vomiting and reflux. Ileus due to small bowel obstruction was suspected and parental feeding was necessary.

At the age of 15 months AST was still elevated (482 U/L and total bilirubin had risen to 3.4 mG/dL (conjugated 2 mG/dL).

At the age of 16 months liver function rapidly detoriorated (fibrinogen 80 mg/dl, thromboplastin time 15%. AST up to about 1900 U/L, ALT up to 350 U/L total bilirubin 19,1 mG/dL, the conjugated fraction being 15 mG/dL) and ascites developed.

He reacted well to acoustic stimuli but was unable to fixate objects and to sit without support. An EEG examination showed diffuse suppression of signals. Finally, intestinal bleeding led to haemorrhagic shock and subsequent fatal multi-organ failure. An autopsy was not performed, but in addition to biopsy probes of the skeletal muscle and the liver, necropsy probes were taken from the heart. The patient was included in a previous study on the molecular genetic and clinical spectrum of POLG mutations \[[@b20]\].

Morphological biochemical and molecular genetic studies were performed, the latter being restricted to analysis of mtDNA since the multisys-temic clinical presentation pointed first of all to a mitochondrial disorder.

Morphology, cytochemistry and biochemistry
------------------------------------------

Liver, skeletal and heart muscle were fixed in 4% buffered formalin and embedded for routine staining procedures. (HE, PAS, van Gieson, Prussian iron stain). For electron microscopy, tissues were fixed in 6.25% glu-taraldehyde/Soerensen phosphate buffer for 2 hrs. After washing in buffered saccharose and osmication (2% distilled water) for 1 hr, tissues were dehydrated in acetone and embedded in Epon (polymerisation at 78°C overnight) for the preparation of semi-thin und ultra-thin sections (coun-terstaining using uranyl acetate and lead citrate). Frozen tissue (stored at -80°C) was used for light microscopical and ultra-cytochemical detection of cytochrome-*c*-oxide as previously described \[[@b23]\]. Immuno-cytochem-istry using the ABC Elite kit (DAKO) was performed as previously described for the detection of cytochrome-c-oxidase subunits II-III and Vab \[[@b24]\], mtTFA, DNA-polymerase **-**γ\[[@b25]\] and mtSSB \[[@b26]\]. Biochemical analysis of the respiratory chain enzymes was performed on homogenates of deep frozen muscle \[[@b27]\]. Measurements were carried out for NADH/CoQ-oxi-doreductase (complex I and II, succinate-oxidoreductase (complex II and III) cytochrome-c-oxidase (complex IV) and citrate synthase.

DNA analysis
------------

mtDNA and nuclear DNA were extracted from skeletal muscle, heart and liver and also from COX negative and COX positive areas and mtDNA copy number and mtDNA/nDNA ratios were determined by real-time PCR using a fluorescent temperature cycler (Light Cycler, Roche Molecular Biochemicals, Mannheim, Germany). The Light Cycler FastStart DNA Master SYBR Green I kit (Roche Molecular Biochemicals) was used \[[@b28], [@b29]\]. We amplified the mtDNA ATP6 gene with unlabelled primers between nucleotide positions 8981 and 9061 with the forward primer, 5′-ACCAATAGCCCTGGCCGTAC-3′ and the backward primer 5′-GGTG-GCGCTTC-CAATTAGGT-3'. For the detection of nDNA we selected exon number 8 of the GAPDH-gene between nucleotide positions 4280--4342 using the forward primer 5′-CGGGGCTCTCCAGAACATC-3′ and the backward primer 5'-ATGACCTTGCCCACAGCCT-3′. The control range was determined for skeletal muscle, liver and heart using 30 control muscle DNA samples, 9 control liver DNA samples, and 3 control heart DNA samples.

Sequencing of the nuclear encoded deoxyguanosine kinase (DGUOK) \[[@b30]\] and POLG was performed as described \[[@b20]\]. Microdissection of frozen liver sections (30 μm) was performed after cytochrome-c-oxidase staining from cytochrome-c-oxidase positive and negative areas by P. A. L. M. (Microlaser Technologies, 82347 Bernried, Germany) for quantitative mtDNA- PCR-analysis.

*In situ* hybridization of mtDNA
--------------------------------

In situ hybridization was performed as previously described \[[@b31]--[@b34]\], on formalin fixed paraffin embedded liver tissue as well as on skeletal and heart muscle using specific probes of mtDNA produced by PCR from isolated human placenta mtDNA. The double stranded DNA was purified by Centricon™ 100 Microconcentrators (Amicon, Beverly, MA, USA). The PCR-DNA fragments were labelled by random primed incorporation of digoxigenin-labelled deoxyuridine triphosphate applying the digoxigenin labelling kit of Boehringer Mannheim.

Results
=======

Liver
-----

Light microscopy of the liver ([Fig. 1](#fig01){ref-type="fig"}) showed a severe alteration of liver parenchyma with massive ballooning of liver cells that often formed giant cells. The cytoplasm of the altered liver cells had a fine vesicular appearance ([Fig. 1B](#fig01){ref-type="fig"}). Often bilirubinostasis was present. The portal tracts were enlarged showing regular pre-existing bile ducts and severe proliferation of bile ductules, containing bile plugs. In the PAS stain no globular diastase resistant cytoplasmic inclusions were found. Besides the altered hepa-tocytes, small islands of better-preserved or normal looking hepatocytes were present ([Fig. 1A](#fig01){ref-type="fig"}). A stain for iron (Perl-stain) was negative.

![Liver, light microscopy. (A) Liver displaying a destroyed architecture. Adjacent to the altered liver parenchyma an island with better structural preservation is seen (↑). (B) Higher magnification showing a vesicular/granular aspect of the hepatic cytoplasm. (Hematoxilin and eosin). Bar A: 50 μM, Bar B: 25 μM.](jcmm0015-0445-f1){#fig01}

Fine structure
--------------

Most of the hepatocytes were stacked full with slightly enlarged mitochondria. These mitochondria had a floccular granular matrix, loss of matrix granules and a reduced amount of cristae ([Fig. 2A, B](#fig02){ref-type="fig"}). Occasionally, mitochondria with tubular cristae formations were also present ([Fig. 2C](#fig02){ref-type="fig"}). Deposits of bile and lipid droplets were a constant feature. Corresponding to the light microscopical findings there were also hepatocytes with a normal content of mitochondria and regular cristae ([Fig. 2D](#fig02){ref-type="fig"}). The rough endoplas-mic reticulum was inconspicuous.

![Ultrastructural changes in the liver. (A) The hepatocytes are stacked full of abnormal mitochondria. (B) The mitochondria have lost their matrix granules and are mainly devoid of cristae. Only single abortive cristae of tubular type are seen. Between the mitochondria occur lipid droplets (L). (C) Hepatocyte full of abnormal mitochondria having cristae of tubular type. (D) Normal hepatocyte with regular ultrastructure. The mitochondria show inconspicuous cristae of lamellar type. Lipid droplets are seen (L). Bar A: 1 μM, Bar B-D: 0.5 μM.](jcmm0015-0445-f2){#fig02}

Cytochemistry
-------------

In most of the hepatocytes cytochrome-c-oxidase (cox-) activity was deficient. ([Fig. 3A](#fig03){ref-type="fig"}) However, there were also small islands with preserved activity ([Fig. 3B](#fig03){ref-type="fig"}). Succinate dehydrogenase was regularly detectable both in the areas with and without deficiency of cytochrome-c-oxidase ([Fig. 3C](#fig03){ref-type="fig"}). At the ultrastructural level occasionally a co-existence of defective and normal reacting mitochondria could be found (not shown).

![Liver. (A) Cytochrome-c-oxidase (cox)-stain, is completely negative in the hepatocytes. (B) Cox-stain of hepatocytes with preserved activity. (C) SDH-stain for comparison with generally retained activity. Bar A-C: 50 μM.](jcmm0015-0445-f3){#fig03}

Immunohistochemistry
--------------------

Immunohistochemistry disclosed a severe loss of cytochrome-c-oxidase subunits II/III, Vab, sparing small islands of hepatocytes. In contrast, the bile ducts reacted normally ([Fig. 4A, B](#fig04){ref-type="fig"}).

![Cytochrome-c-oxidase immunohistochemistry in the liver. (A) The subunit II/III lacks in most of the hepatocytes but is retained in the biliary ducts (↑). (B) Subunit Vab. A mosaic defect pattern is seen with coexisting deficient and reacting hepatocytes. The bile duct epithelium reacts normally (↑). Bar A, B: 50 μM.](jcmm0015-0445-f4){#fig04}

There was also a severe defect of DNA-polymerase γ sparing, however, small hepatocytic foci ([Fig. 5](#fig05){ref-type="fig"}). Also, mtSSB and mtTFA were partially deficient leading to the coexistence of both defective and normal-reactive hepatocytes ([Fig. 6A, B](#fig06){ref-type="fig"}).

![Polymerase -γ immunohistochemistry in the liver. (A) Liver with POLG-mutation showing a severe defect. Small islands of hepatocytes have retained some protein. (B) Higher magnification to show the coexistence of defective hepatocytes and hepatocytes with demonstrable polymerase -γ protein. (C) In a control liver polymerase -γ is homoge-nously expressed in the hepatocytes. Bar A: 50 μM, Bar B, C: 25 μM.](jcmm0015-0445-f5){#fig05}

![Liver. Immunohistochemistry of (A) mtSSB, (B) mtTFA. Both proteins are focally lacking. Bar A, B: 25 μM.](jcmm0015-0445-f6){#fig06}

In *situ* hybridization of mtDNA
--------------------------------

*In situ* hybridization of mtDNA disclosed a severe reduction of mtDNA in the altered hepatocytes ([Fig. 7A, B](#fig07){ref-type="fig"}), but there were multiple small foci of hepatocytes with preserved staining ([Fig. 7A, C](#fig07){ref-type="fig"}). No staining defect could be found in the bile duct epithelium ([Fig. 7B](#fig07){ref-type="fig"}).

![Liver in situ hybrization of mtDNA. (A) Severe depletion of mtDNA molecules in the hepatocytes. In an island of hepatocytes mtDNA can be detected (↑) see also C. (B) Higher magnification to show the mtDNA defect in the hepatocytes. The bile duct epithelia react normally (↑). (C) Higher magnification. Residual mtDNA can be demonstrated in the cytoplasm of the hepatocytes. Bar A: 50 μM, Bar B, C: 25 μM.](jcmm0015-0445-f7){#fig07}

Heart and skeletal muscle
-------------------------

In the heart ([Fig. 8](#fig08){ref-type="fig"}) and skeletal muscle single cells/fibres were present with an accumulation of lipids and mitochondria. The mitochondria were enlarged and had irregular cristae of a tubular type. However, no defects of cytochrome-c-oxidase could be detected ([Fig. 9](#fig09){ref-type="fig"}). Succinate dehydrogenase was also normal.

![Heart ultrastructure. (A) Abnormal cardiomyocyte exhibiting a high content of mitochondria. Higher magnification to show the atypcical mitochondria with tubular and circular cristae. Original magnification, Bar A: 1 μM, Bar B: 0.4 μM.](jcmm0015-0445-f8){#fig08}

![Cytochrome-c-oxidase cytochemistry. No defect is seen in the mitochondria of the heart both at light (A) and electron microscopy (B). Also in the skeletal muscle cytochrome-c-oxidase activity is unaltered (C). Bar A, B: 25 μM, Bar C: 0.5 μM.](jcmm0015-0445-f9){#fig09}

Furthermore, immunohistochemistry disclosed no defects of cytochrome-c-oxidase subunits II/III, Vab and of DNA- polymerase γ in the skeletal muscle. Also no defects were present for mtTFA and mtSSB in the heart. In the skeletal muscle mtTFA and mtSSB could not be demonstrated with confidence, even in controls.

*In situ* hybridization of mtDNA could not detect a clear reduction of mtDNA in the heart. In the skeletal muscle the signal intensity was generally weak apparently because of artificial influences.

Biochemistry
------------

Analysis of the respiratory chain revealed a severely reduced activity of all mtDNA-encoded enzyme complexes (I. III, IV) in the liver ([Table 1](#tbl1){ref-type="table"}). In the heart the enzyme activities were below the normal range; however, skeletal muscle showed normal respiratory chain activities ([Table 1](#tbl1){ref-type="table"}).

###### 

Respiratory chain complex activities

  Tissue                    Skeletal muscle       Heart               Liver
  ------------------------- --------------------- ------------------- -------
  Complex I U/UCS           0.31                  0.01                0.00
  (normal 0.17--0.56)       (normal 0.09--0.22)   (normal 0.5--1.2)   
  Complex II+III U/UCS      0.15                  0.02                0.07
  (normal 0.08--0.45)       (normal 0.06--0.1)    (normal 0.5--0.8)   
  Complex IV U/UCS          1.3                   0.51                0.12
  (normal 1.1--5.0)         (normal 0.6--1.3)     (normal 1.3--2.6)   
  Citrate synthase U/gNCP   55                    246                 81
  (normal 45--100)          (normal 250--350)     (normal 25--35)     

Molecular genetics/mtDNA-Quantification
---------------------------------------

A severe depletion of mtDNA was found in the liver and a less severe but still significant depletion was detected in skeletal muscle and in heart homogenates ([Table 2](#tbl2){ref-type="table"}).

###### 

mtDNA Depletion Test

  Tissue             Skeletal muscle   Heart    Liver       COX+liver cells   COX-liver cells
  ------------------ ----------------- -------- ----------- ----------------- -----------------
  mtDNA/nDNA ratio   0.1               0.891    0.05        0.061             0.007
  Normal range       0.25--4.0         1--5.0   0.25--4.0                     

The quantitative analysis of mtDNA in cox-negative and cox-positive hepatocytes revealed a very low copy number of mtDNA in cox-negative and a significantly higher number in cox-positive hepatocytes ([Table 2](#tbl2){ref-type="table"}). But also in the cox-positive cells the mtDNA copy number was lowered, measuring only about 24% of the lowest normal value.

Molecular genetic analysis of DNA isolated from blood cells of the index patient revealed two heterozygote missense mutations in the POLG gene, A467T and K1191N. The A467T mutation has been frequently described in patients with Alpers-Huttenlocher syndrome, but also in other POLG phenotypes. The other mutation (K1191N) affects a highly conserved amino acid in the polymerase domain in transwith the A467T mutation \[[@b20]\]. Both parents harboured one of the two mutations found in the child proving compound heterozygosity.

Discussion
==========

Mitochondrial DNA depletion syndrome is an autosomal recessive disorder affecting either selectively or in combinations various organs, especially the liver, heart, kidneys, skeletal muscle and brain. In contrast to other mitochondrial diseases, severe depletion of mtDNA often affects the liver and can lead to liver failure. \[[@b6]--[@b11]\]. Depletion of mtDNA in the liver has also been found in oncocytic hepatocytes \[[@b35]\], associated with defects of the respiratory chain \[[@b25]\] most probably as an effect of cellular ageing \[[@b31]\].

The enzyme responsible for mtDNA replication is Pol γ, which consists of a 140 kD catalytic polypeptide (encoded by POLG or POLG1) and two identical 55 kD accessory subunits (encoded by POLG2) that are required for an increased DNA affinity and highly processive DNA synthesis \[[@b12], [@b14], [@b36], [@b37]\]. The majority of mutations involved with Pol γ have been genetically linked to the POLG gene \[[@b15]--[@b19]\] while mutations in POLG2 are rare \[[@b38]\].

Over 150 disease causing mutations have been reported in POLG where the A467T mutation of POLG has been observed to be the most frequent \[[@b12], [@b20], [@b21]\] (see also <http://tools.niehs.nih.gov/polg/>). The A467T mutation compromises the interaction with the accessory subunit and decreases polymerase activity \[[@b12]\]. Patients heterozygous for the A467T mutation, like the patient described here, are usually more severely affected than A467T homozygotes \[[@b20], [@b39]\]. Patients with compound heterozygous mutations involving A467T display a wide clinical phenotype from PEO to Alpers-Huttenlocher syndrome, but, in general, mutations in the polymerase domain, such as the K1191N, are associated with Alpers syndrome \[[@b40]\]. The fatal liver failure in our patient was comparable with the liver failure seen in Alpers-Huttenlocher syndrome; however, the lack of epilepsy makes the clinical presentation atypical. Although clinically silent the child also had mitochondrial cardiomyopathy. Thus, our studies provide evidence that the heart muscle might also be affected by mutations in POLG.

Furthermore, our study confirms the occurrence of tissue dependent defects \[[@b19], [@b41]--[@b44]\]. Whereas only a mild mitochondrial cytopathy of the heart and skeletal muscle was seen on single cells/ fibre level a severe but nevertheless non-homogenous defect was detected in the liver. The finding of non-homogenous liver involvement has been previously reported in three studies \[[@b10], [@b11], [@b63]\]. The underlying pathogenic mechanisms were, however, not further elucidated. In the present study, we analyzed the defect pattern by cytochemical and immunocytochemical detection of cytochrome-c-oxidase and for the first time combined the findings with *in situ* hybridization of mtDNA and additional quantitative PCR analysis of mtDNA on isolated cox-positive and cox-negative liver cells.

In whole liver preparations the mtDNA copy number proved to be 80% reduced (referred to the lowest normal value). In isolated cox-positive liver cells mtDNA was similarly depleted. Cox-negative liver cells, however, exhibited an even more severe depletion. Their mtDNA content was about 9 times lower than that of cox-positive liver cells. This quantitative analysis correlated well with the results obtained by *in situ* hybridization of mtDNA. Interestingly, no defect could be localized in the biliary duct cell system. Thus, our findings suggest that even when mtDNA is depleted in liver, the amount of depletion has to reach a critical threshold in single cells in order to express the biochemical defect and this may be variable within single cells. Thereby, similar to the skeletal muscle \[[@b45], [@b46]\] a mosaic defect pattern may result \[[@b63]\]. In the skeletal muscle 0.01 mtDNA/μm^3^ has been found sufficient for residual cytochrome c oxidase activity \[[@b46]\]. Therefore, a slight increase in the mtDNA copy number might be enough to traverse the threshold value to regain the normal respiratory function. This observation may open new possibilities for further therapy trials and may explain the occasionally observed reversibility of mtDNA depletion \[[@b47]--[@b49]\]. The mechanisms, however, underlying the expression of tissue selectivity and the reversibility remain still unclear \[[@b50], [@b51]\].

Besides tissue specific isoforms of enzymes enrolled in DNA replication and maintenance, oxidative damage from free radicals might be a causative factor since Pol γ is susceptible to oxidative damage *in vitro*\[[@b52], [@b53]\]. In the present case, the compound heterozygous mutations in POLG presented as immunohistochemically severely reduced Pol γ protein and a mosaic pattern of cox-staining and mtDNA levels. In a previous case, with DNA depletion caused by a homozygous deoxyguanosine kinase gene (DGUOK) mutation \[[@b54]\] expression of Pol γ was shown to be normal \[[@b11]\].

In our study, we also tested the expression of mitochondrial transcription factor (mtTFA) and of mitochondrial single stranded protein (mtSSB), which both are involved in mtDNA-replication. H-mtTFA is a 25 kD protein, indispensable for transcription and replication of mtDNA \[[@b55]\]. The protein bends and unwinds mtDNA, thus priming transcription and replication \[[@b5], [@b56]\]. In the liver of the present patient a mosaic defect pattern of both proteins existed. In a previously described case \[[@b11]\] with a hepatic form of mtDNA depletion caused by a homozygous DGUOK gene mutation \[[@b54]\] mtTFA and mtSSB were also defective, the latter, however only in single abnormal hepatocytes. In a previous study on parathyroids with defects of cytochrome-c-oxidase both mtTFA and polymerase γ were regularly expressed \[[@b57]\].

It is generally accepted that h-mtTFA mirrors the mtDNA status of the cell, but it is most likely that reduction of h-mtTFA represents a secondary phenomenon as it is also reduced in cell lines where mtDNA copy number was experimentally reduced \[[@b58], [@b59]\]. Therefore, it appears that similar as in Saccharomyces cerevisiae \[[@b60]\] in the liver mitochondrial proteins are soon degraded when they are not properly assembled, *e.g.* because of reduced binding sites. A similar observation concerns the single strand binding protein (mtSSB). As mtSSB is essential for mtDNA replication and thus the maintenance of the DNA, its amount directly correlates with the mtDNA content \[[@b61]\]. Consequently, it may be assumed that the reduced appearance of mtTFA and mtSSB mirrors the replicative failure of mtDNA. It therefore appears that depletion represents a dynamic process leading to additional secondary alterations in the mtDNA replicative machinery which might also aggravate the degree of mtDNA depletion and be a contributory cause of the mosaic defect pattern in the liver.

We also addressed the question of comorbitity with other chronic liver diseases \[[@b22]\]. But there was no evidence for infectious liver disease, paucity of intrahepatic bile ducts, fetal hemochromatosis α-1-antitrypsin deficiency or cystic fibrosis as potential contributing factors.

In conclusion, the presented results illustrate that morphologi-cal/cytochemical data and in situ hybridization of mtDNA provide valuable information in diagnosing mtDNA depletion. mtDNA depletion in the liver should be suspected on light microscopy when severe ballooning, bilurubinostasis and steatosis and giant hepato-cytes are present. On electron microscopy the most characteristic signs for mtDNA depletion are the accumulation of abnormal mitochondria with tubular cristae or lack of cristae \[[@b11], [@b62]\]. Cytochemistry/immunocytochemistry combined with *in situ* hybridization of mtDNA are especially suited for the detection of mosaic tissue involvement. If biochemical evidence (decreased activity of respiratory chain complexes I, III and IV) in liver also supports the mitochondrial origin, it can give further support for the depletion, if molecular genetic data are in the border-line range. Our data show that mutations in POLG lead to heterogenous depletion of mtDNA in liver, skeletal and heart and to a mosaic defect pattern even in the severely affected liver. Secondary dysregulation of other proteins involved in mtDNA maintenance like mtTFA and mtSSB probably aggravate the defect and may thereby promote the development of a mosaic defect pattern. The results help to explain the occasionally observed recovery from mtDNA depletion.
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